Apolipoprotein B (
apoB) and non-
high-density lipoprotein cholesterol (non-HDL-C) are
cardiovascular disease risk markers, although data in adults with
type 1 diabetes mellitus (DM) are limited. We hypothesized that elevated
apoB and non-HDL-C would be associated with greater odds of coronary artery calcification progression (CACp), a measure of
coronary atherosclerosis, than either category alone in adults with type 1 DM. We grouped subjects with type 1 DM (n = 652) into 4 groups: elevated
apoB (≥90 mg/dl) and elevated non-HDL-C (≥130 mg/dl), elevated non-HDL-C alone, elevated
apoB alone, and normal
apoB and non-HDL-C. We used logistic regression to examine the associations between the groups and CACp for a period of 6 years. We performed sensitivity analyses with elevated
apoB and non-HDL-C redefined as at or more than the cohort means (91.4 and 119.0 mg/dl, respectively). Subjects with elevated
apoB and non-HDL-C had greater odds of CACp compared with those with normal
apoB and non-HDL-C (odds ratio 1.90, 95% confidence interval 1.15 to 3.15) and compared with subjects with elevated
apoB alone (odds ratio 2.86, 95% confidence interval 1.43 to 5.74) adjusting for age, gender, duration,
hemoglobin A1c, and
statins. Similar results were obtained with elevated
apoB and non-HDL-C defined as at or more than the cohort means. In conclusion, elevated
apoB and non-HDL-C carry a greater risk of
atherosclerosis than elevated
apoB in the absence of elevated non-HDL-C in adults with type 1 DM. These data suggest that
apoB and non-HDL-C should be viewed as complementary rather than competitive indexes of
cardiovascular disease risk in type 1 DM.